Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Charcot-Marie-Tooth Disease

NCT03254199 is registered in ClinicalTrials.gov with Flex Pharma, Inc. as lead sponsor.

NCT NCT03254199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03254199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Charcot-Marie-Tooth Disease
Lead sponsor
Flex Pharma, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
October 16, 2017
Completion date
July 27, 2018
Enrollment
27 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

charcot-marie-tooth disease